Vaxxinity, Inc. (VAXX)
USD 0.05
(200.0%)
USD 0.05
(200.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -58.28 Million USD | 99.92% |
| 2022 | -75.97 Million USD | 39.25% |
| 2021 | -125.07 Million USD | -287.45% |
| 2020 | -32.28 Million USD | -136.31% |
| 2019 | -13.66 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -13.44 Million USD | 6.81% |
| 2023 Q2 | -14.42 Million USD | 23.29% |
| 2023 Q1 | -18.8 Million USD | 9.68% |
| 2023 FY | -58.28 Million USD | 23.29% |
| 2023 Q4 | -11.65 Million USD | 13.35% |
| 2022 Q4 | -20.82 Million USD | -5.34% |
| 2022 Q3 | -19.76 Million USD | -14.77% |
| 2022 Q2 | -17.22 Million USD | 5.18% |
| 2022 Q1 | -18.16 Million USD | 62.04% |
| 2022 FY | -75.97 Million USD | 39.25% |
| 2021 Q4 | -47.85 Million USD | -58.06% |
| 2021 Q3 | -30.27 Million USD | -12.99% |
| 2021 Q2 | -26.79 Million USD | -32.28% |
| 2021 FY | -125.07 Million USD | -287.45% |
| 2021 Q1 | -20.25 Million USD | -80.45% |
| 2020 Q2 | -5.81 Million USD | -228465.82% |
| 2020 FY | -32.28 Million USD | -136.31% |
| 2020 Q1 | -2545.00 USD | 0.0% |
| 2020 Q4 | -11.22 Million USD | 11.57% |
| 2020 Q3 | -12.69 Million USD | -118.22% |
| 2019 FY | -13.66 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| America Great Health | -492.64 Thousand USD | -11731.059% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -512.366% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -94.329% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 13.193% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -267.891% |
| Better Therapeutics, Inc. | -38.26 Million USD | -52.331% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -38.53% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -386.925% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -72.217% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -69.34% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 46.264% |
| Evolutionary Genomics, Inc. | -2.01 Million USD | -2793.558% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -71.416% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -24.14% |
| Innovation1 Biotech Inc. | -1.36 Million USD | -4162.513% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -192.312% |
| Molecular Templates, Inc. | -10.46 Million USD | -456.899% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | -314.813% |
| NexImmune, Inc. | -29.19 Million USD | -99.658% |
| Orgenesis Inc. | -53.63 Million USD | -8.668% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -13.629% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -74608.076% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -261.004% |
| Scopus BioPharma Inc. | -11.71 Million USD | -397.53% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 88.443% |
| Statera Biopharma, Inc. | -98.34 Million USD | 40.733% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -744.955% |
| Trevena, Inc. | -35.28 Million USD | -65.169% |
| Vaccinex, Inc. | -22.88 Million USD | -154.686% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -5466.975% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -14.976% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -702.491% |